- Group leader
- +47 22 78 19 82
Jorrit is involved in all projects.
Jorrit is involved in all projects.
Helene leads her own project group centered around two main goals 1) to understand how autophagy is turned off in a multicellular organism and 2) to identify novel therapies for MLL-rearranged leukemia with the help of a fruit fly model of leukemia.
Nacho joined the Enserink group in 2013. In 2017 he obtained a 4 year researcher fellowship to combine classical drug screenings with state-of-the-art computational approaches to find new drugs to treat drug-resistant fungal infections in cancer patients.
Pilar joined the Enserink group as a post-doctoral researcher in January 2014 with a 2-years grant funded by the Fundación Alfonso Martín Escudero. She works in a personalized-medicine platform for leukemia patients, testing the sensitivity of primary cells from patients or healthy donors to a panel of anticancer drugs.
Sara is independently funded by the Fundación Alfonso Martín Escudero. She joined the Enserink group as a post-doc on August, 2017 and she is studying mechanisms of autophagy induction using the model organism budding yeast.
Nathalia's work is to develop and establish a genome-wide study in autophagy using budding yeast to further understand autophagy dynamic response in higher eukaryotes.
Miriam joined the group in July 2020 and is working on elucidating the molecular mechanisms regulating autophagy termination and their implications for human cancer using Drosophila as a model system.
Jonathan works developing new immunotherapies for cancer patients. For this purpose, he engineers both proteins and functions of immune cells, particularly T, NK and iPS cells.
Benjamin project is focused on cancer immunotherapy, molecular engineering, cell-based immunotherapy, and cell fate reprogramming.
Amani joined the group in September 2020 and is working on identifying novel regulators of autophagy termination and understanding the underlying molecular mechanisms both in vitro and in vivo using Drosophila as a model.
Aram is combining mathematical modeling with various unsupervised and semi-supervised machine learning strategies to perform guided exploration in high-dimensional genetic perturbation screens; with primary focuses on characterizing fitness landscapes in cancer and system-control of autophagy dynamics in yeast.
Jeanne is working on the development of new antimycotics to treat drug-resistant fungal infections. She started her PhD. project with Nacho Garcia in 2019.
Linda´s work supports the experimental validation of the genome-wide screening for functional analysis of autophagy response in yeast.
Julie is working on MLL-rearranged leukemia and how proliferating hemocytes can be reprogrammed towards cell death. She started her M.Sc. project with Helene Knævelsrud in 2019.
Andrea is looking into improving systems for personalized medicine in lung cancer through the use of 3D cell cultures and machine learning strategies.
Ida is characterizing novel combination therapy that prevents resistance in patients after TKI treatments. She started her M.Sc. project with Carmen Herrera in 2019. She obtained her B.Sc. from University of Bergen.
Alberto is ..
Linda is working on uncovering the role of the ubiquitin proteasome system in autophagy termination. She joined the project group of Helene Knævelsrud in December 2020 to start her MSc project with Miriam Formica as a supervisor.
Halvor is working on modulating autophagy in the treatment of kidney cancer associated with a rare human syndrome. He joined the project group of Helene Knævelsrud in January 2021.